These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 731414)

  • 21. Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat. Hydrolysis of glucuronic acid conjugates in the gut lumen.
    Parker RJ; Hirom PC; Millburn P
    Xenobiotica; 1980 Sep; 10(9):689-703. PubMed ID: 7445530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic availability of oral slow-release morphine in man.
    Moore RA; McQuay HJ; Bullingham RE; Baldwin D; Allen MC
    Ann Clin Biochem; 1985 May; 22 ( Pt 3)():226-31. PubMed ID: 4026183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-pass effect of nalorphine in rats.
    Iwamoto K; Klaassen CD
    J Pharmacol Exp Ther; 1977 Nov; 203(2):365-76. PubMed ID: 909069
    [No Abstract]   [Full Text] [Related]  

  • 24. Complications in the estimation of hepatic blood flow in vivo by pharmacokinetic parameters. The area under the curve after the concomitant intravenous and intraperitoneal (or intraportal) administration of acetaminophen in the rat.
    Pang KS; Gillette JR
    Drug Metab Dispos; 1978; 6(5):566-76. PubMed ID: 30607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of lorazepam in human beings: enterohepatic recirculation and first-pass effect.
    Herman RJ; Van Pham JD; Szakacs CB
    Clin Pharmacol Ther; 1989 Jul; 46(1):18-25. PubMed ID: 2743706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH; Lee MG
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of the normal folate enterohepatic cycle.
    Steinberg SE; Campbell CL; Hillman RS
    J Clin Invest; 1979 Jul; 64(1):83-8. PubMed ID: 447863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat.
    Papathanasiou T; Juul RV; Gabel-Jensen C; Kreilgaard M; Lund TM
    Pharm Res; 2016 Nov; 33(11):2630-43. PubMed ID: 27380190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal and hepatic first-pass metabolism of aspirin in rats.
    Iwamoto K; Takei M; Watanabe J
    J Pharm Pharmacol; 1982 Mar; 34(3):176-80. PubMed ID: 6121895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic assessment of the sites of first-pass metabolism of BMS-181101, an antidepressant agent, in rats.
    Vachharajani NN; Shyu WC; Shah VR; Barbhaiya RH
    J Pharm Pharmacol; 1998 Mar; 50(3):275-8. PubMed ID: 9600718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of high-dose intravenous morphine in cardiac surgery patients.
    Stanski DR; Greenblatt DJ; Lappas DG; Koch-Weser J; Lowenstein E
    Clin Pharmacol Ther; 1976 Jun; 19(6):752-6. PubMed ID: 1269215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers.
    Lötsch J; Weiss M; Ahne G; Kobal G; Geisslinger G
    Anesthesiology; 1999 Apr; 90(4):1026-38. PubMed ID: 10201674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of oral and intravenous route pharmacokinetics, plasma protein binding, and uterine tissue dose metrics of bisphenol A: a physiologically based pharmacokinetic approach.
    Teeguarden JG; Waechter JM; Clewell HJ; Covington TR; Barton HA
    Toxicol Sci; 2005 Jun; 85(2):823-38. PubMed ID: 15746009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.
    Kim TH; Shin S; Landersdorfer CB; Chi YH; Paik SH; Myung J; Yadav R; Horkovics-Kovats S; Bulitta JB; Shin BS
    AAPS J; 2015 Sep; 17(5):1210-23. PubMed ID: 25990964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation.
    Säwe J; Kager L; Svensson Eng JO; Rane A
    Br J Clin Pharmacol; 1985 Apr; 19(4):495-501. PubMed ID: 3994897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
    Fukuyama T; Yamaoka K; Ohata Y; Nakagawa T
    Drug Metab Dispos; 1994; 22(3):479-85. PubMed ID: 8070327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic model for enterohepatic recirculation in the rat: phenolphthalein, a model drug.
    Colburn WA; Hirom PC; Parker RJ; Milburn P
    Drug Metab Dispos; 1979; 7(2):100-2. PubMed ID: 38070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.